COVID-19 & Cancer
We have collected trusted information about COVID-19 that is especially relevant to people with breast cancer. This page will be updated regularly during the pandemic.
We have collected trusted information about COVID-19 that is especially relevant to people with breast cancer. This page will be updated regularly during the pandemic.
On December 16, 2020, the FDA approved margetuximab-cmkb (MARGENZA™) in combination with chemotherapy, for treating metastatic HER2-positive breast cancer.
Read further for an overview of current research and new therapies for breast cancer brain metastasis (BCBM).
Learn more about “washout periods” — what they are, why they are required, the ethical issues that exist, and the potential solutions being discussed.
Next-generation sequencing (NGS) is when all of the genes in a tumor are tested for genomic mutations. Read the discussions about whether NGS improves survival and quality of life, and the ESMO recommendations regarding NSG for patients with metastatic cancers (including breast).
Which therapy to use for the first, second or third line of treatment for metastatic breast cancer is now under rigorous research as more new therapies are available for treating MBC.
for past articles or specific information.